Research on Simbionix PROcedure Rehearsal Software Awarded Magna Cum Laude Prize at CIRSE 2009
Imperial College of
Magna Cum Laude EPOS Award at the CIRSE 2009 congress in
The PROcedure Rehearsal Studio(TM), introduced by Simbionix last year, is
the world’s first patient specific system to enable clinicians to create
practice scenarios based on their patient’s unique anatomy as reconstructed
from CTA or MRA data.
Preliminary data from ongoing research by the European Virtual Reality
Endovascular Research Team (EVEResT) suggests that patient-specific rehearsal
may enhance the performance of interventionalists in subsequent endovascular
procedures. The preliminary data also suggested that after rehearsal,
endovascular surgery is carried out more rapidly with less use of contrast
and fluoroscopy and to a higher qualitative standard, compared to those
interventions preceded by a generic warm-up case, or no warm-up at all.
Professor
College remarks: “We are pleased to report on the strong correlation between
the virtual and real operation with regards to the angiography images,
endovascular access and material used during the intervention. The Rehearsal
Studio was able to adequately predict the optimal material for the specific
case at hand. Further research into the PROcedure Rehearsal Studio(TM) is
expected to determine if this technology can indeed help to improve the
technical skills of the interventionalist and tailor these skills to the
challenges of a specific patient. The preliminary results already demonstrate
shorter procedure time with less use of contrast; the end goal of the
application of this technique will of course be to enhance patient safety and
outcome.”
Mr. Ran Bronstein, President and COO at Simbionix adds: “We are very
pleased with the results of the research work conducted on our newest system.
The PROcedure Rehearsal Studio(TM) is an innovative product that utilizes a
unique technology which was developed following intensive R&D efforts. Based
on initial reactions, I believe it will change the way physicians practice
and perform today.”
About Imperial College Londonthe EVEResT Research Group
The EVEResT research group, led by Professor
multicenter collaboration between the Imperial College London in the U.K.,
the University Hospital Ghent in
Sheffield Vascular Institute in the U.K.(Prof.
The research group is multidisciplinary in nature, consisting of vascular
surgeons, radiologists and cardiologists. Its main goal is to provide a
platform for research into medical simulation and to aid the process of
validation and implementation of endovascular simulation as both a training,
credentialing and procedure rehearsal tool.
About Simbionix USA Corporation
Simbionix is the leader in the development and delivery of innovative and
effective virtual reality simulation products and solutions for clinical
education and training of medical professionals. The products are designed to
accelerate best-practice medical training, advance clinical performance, and
improve patient safety.
The Simbionix product line includes the ANGIO Mentor(TM) line for
endovascular procedures, LAP Mentor(TM) line for laparoscopic surgical
procedures, GI Mentor(TM) for upper and lower gastrointestinal procedures and
the URO Mentor(TM) for urological procedures. In addition, Simbionix
distributes the HystSim(TM) for hysteroscopic procedures. Each simulation
platform is a leading simulator in the relevant clinical area.
Simbionix simulation products have been validated in several scientific
studies and the company cooperates closely with both industry and leading
medical institutions to develop the most advanced simulators for the training
and assessment of medical professionals.
Galia Zilbershtein-Salant
Exhibition Manager
Simbionix
Tel: +972-8-9211177
galia@simbionix.com
SOURCE Simbionix Ltd.